EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lychee Seed Extract Targets Proliferation, Differentiation, and Cell Cycle Proteins to Suppress Human Colorectal Tumor Growth in Xenograft Models

Szu-Nian Yang iD, Yi-Ping Chang, Oscar C Y Yang, Chi-Sheng Wu, Chiu-Chen Huang, Jia-Feng Chang iD, Chia-Ming Liang, Shun-Tai Dai, Lung Chen, Chih-Ping Hsu

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26199786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Szu-Nian Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan 330023, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Plant Extracts, Seeds, Cell Cycle Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taoyuan Branch of Taipei Veterans General Hospital, Renal Care Research and Health Promotion Association, National Science and Technology Council, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) remains a leading global health challenge, and natural products are increasingly explored for their multi-targeted therapeutic potential. Litchi chinensis seed extract (LCSE) has shown promising anti-cancer activity in vitro, though its in vivo effects remain underexplored. LCSE was analyzed by colorimetric assays and HPLC to quantify the phytochemical composition. Nude mice bearing HT-29 or SW480 xenografts were orally administered LCSE (0.1 or 0.6 g/kg) daily for 14 days. Tumor volume was measured, and immunohistochemistry was used to assess EGFR, p21, p53, Ki-67, CEA, CK20, CDX2, and Bax expression. Phytochemical profiling demonstrated LCSE contains abundant phenolics and flavonoids, with gallic acid as a predominant constituent, underscoring the potential bioactive properties. LCSE significantly inhibited tumor growth in HT-29 xenografts and dose-dependently reduced EGFR, p21, p53, cell cycle proteins and proliferation/differentiation markers. In SW480 tumors, inhibitory effects were evident primarily at the higher dose, with limited reduction in p53 expression. Bax levels remained unchanged in both models, indicating a non-apoptotic mechanism. No systemic toxicity was observed in treated mice. LCSE exhibits dose-dependent anti-tumor activity in CRC xenografts, likely mediated through suppression of proliferation and modulation of key regulatory proteins rather than apoptosis. These findings support LCSE as a safe, multi-target botanical candidate for CRC intervention and justify further mechanistic and translational studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsPlant ExtractsSeedsCell Cycle ProteinsCell DifferentiationAntineoplastic Agents, PhytogenicHumansAnimalsCell ProliferationXenograft Model Antitumor AssaysMiceMice, NudeHT29 CellsCell Line, TumorApoptosis

Stichwörter der Autor:innen

EGFRKi-67chemopreventioncolorectal cancerlychee seed extractp21p53xenograft model

Substanzen

Plant ExtractsCell Cycle ProteinsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Psychiatry, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan 330023, Taiwan.
  • Department of Oral Hygiene, Jen-Teh Junior College of Medicine, Nursing and Management, Miaoli 356006, Taiwan.
  • Division of Nephrology, Department of Internal Medicine, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan 330023, Taiwan.
  • Department of Healthcare Information and Management, Taoyuan Campus, Ming Chuan University, Taoyuan 333321, Taiwan.
  • Division of Hematology and Oncology, Department of Internal Medicine, Taipei Veterans General Hospital, Taoyuan Branch, Taoyuan 330023, Taiwan.
  • Renal Care Research and Health Promotion Association, New Taipei City 220050, Taiwan.

ORCID-Profile: Szu-Nian Yang, Jia-Feng Chang

Förderung

  • Taoyuan Branch of Taipei Veterans General Hospital
  • Renal Care Research and Health Promotion Association
  • National Science and Technology Council, Taiwan

Zitieren

APA

Yang, S. N., Chang, Y. P., Yang, O. C. Y., Wu, C. S., Huang, C. C., Chang, J. F., Liang, C. M., Dai, S. T., Chen, L., & Hsu, C. P. (2025). Lychee Seed Extract Targets Proliferation, Differentiation, and Cell Cycle Proteins to Suppress Human Colorectal Tumor Growth in Xenograft Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26199786

Vancouver

Yang SN, Chang YP, Yang OCY, Wu CS, Huang CC, Chang JF, et al. Lychee Seed Extract Targets Proliferation, Differentiation, and Cell Cycle Proteins to Suppress Human Colorectal Tumor Growth in Xenograft Models. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26199786

BibTeX
@article{Yang2025,
  author = {Yang, Szu-Nian and Chang, Yi-Ping and Yang, Oscar C Y and Wu, Chi-Sheng and Huang, Chiu-Chen and Chang, Jia-Feng and Liang, Chia-Ming and Dai, Shun-Tai and Chen, Lung and Hsu, Chih-Ping},
  title = {Lychee Seed Extract Targets Proliferation, Differentiation, and Cell Cycle Proteins to Suppress Human Colorectal Tumor Growth in Xenograft Models},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26199786}
}
Kostenlos starten →